Among them, vascular endothelial cells (ECs) promote leukemia cell proliferation, drug resistance, and recurrence through paracrine vascular endothelial growth factor (VEGF), adhesion, and fusion with leukemia cells, resulting in poor prognosis (5–8). Here, VEGFA is linked to leukemia.